Central African Republic vs Papua New Guinea: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Central African Republic
45.0%
in 2025
Papua New Guinea
44.0%
in 2025
Central African Republic rank
158th
Papua New Guinea rank
159th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Central African Republic
- Papua New Guinea
How they compare
Central African Republic currently reports 45.0% against 44.0% in Papua New Guinea, a difference of 1.0%.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was Papua New Guinea ahead.
Central African Republic ranks 158th and Papua New Guinea ranks 159th of 194 countries.
Central African Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 32.7% | 14.6% | 18.1% | Central African Republic |
| 2020s | 38.0% | 37.8% | 0.2% | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Central African Republic or Papua New Guinea?
- Central African Republic, at 45.0% against 44.0% in Papua New Guinea as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Central African Republic and Papua New Guinea?
- 1.0%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Papua New Guinea?
- 18 years are reported by both, from 2008 to 2025.
- How do Central African Republic and Papua New Guinea rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Central African Republic ranks 158th and Papua New Guinea ranks 159th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.